Patients' perspective on emergency treatment of ophthalmologic diseases during the first phase of SARS-CoV2 pandemic in a tertiary referral center in Germany - the COVID-DETOUR questionnaire study

Christoph Ehlken, Constantin von Medem, Maya Lüdemann, Anna Maria Kirsch, Johann Baptist Roider, Christoph Ehlken, Constantin von Medem, Maya Lüdemann, Anna Maria Kirsch, Johann Baptist Roider

Abstract

Background: During the first wave of the COVID-19 pandemic, the need of treatment of urgent ophthalmological diseases and the possible risk of a SARS-CoV-2 infection had to be weighed against each other. In this questionnaire study, we aimed to analyze potential barriers and patients' health beliefs during and after the lockdown early 2020 in a tertiary referral center in Kiel, Germany.

Methods: Patients admitted for the treatment of urgent ophthalmic diseases between March 1st, 2020, and June 3rd, 2020, were asked to participate in a questionnaire study. After informed consent was obtained, patients were interviewed using a standardized questionnaire which addressed aspects of their medical history, their health beliefs concerning the COVID-19 pandemic and barriers on their way to the treatment center. The study group was subdivided into two subgroups, depending on the occurrence of their symptoms, before and after the lockdown was ended on April 20th, 2020.

Results: Ninety-three patients were included, 43 in subgroup A (before April 20th) and 50 in subgroup B (April 20th or later). Retinal disorders were the most common causes for admission (approximately 60%).. Only 8 patients (8.6%) experienced a delay between their decision to visit a doctor until the actual examination. Every fourth patient was afraid of a COVID-19 infection, and expected a higher likelihood for an infection at the hospital. Patients with comorbidities tended to be more likely to be afraid of an infection (correlation coefficient 0.183, p = 0.0785) and were significantly more likely to be concerned about problems with organizing follow-up care (corr. Coefficient 0.222, p = 0.0328). Higher age was negatively correlated with fear of infection (corr. Coefficient - 0.218, p-value 0.034).

Conclusion: In this questionnaire study, only a minority of patients indicated a delay in treatment, regardless of whether symptoms occurred before or after the lockdown before April 20th, 2020. While patients with comorbidities were more concerned about infection and problems during follow-up care, patients of higher age - who have a higher mortality - were less afraid. Protection of high-risk groups should be prioritized during the SARS-CoV-2 pandemic.

Trial registration: The study was registered as DRKS00021630 at the DRKS (Deutsches Register Klinischer Studien) before the conduction of the study on May 5th, 2020.

Keywords: COVID; Delay in treatment; Emergency; Pandemic.

Conflict of interest statement

CE received fees for advisory boards by Bayer Vital GmbH and presentation fees by Allergan GmbH, non of which interfere with the conception, conduction or analysis of the presented study. CM, ML, AK and JR declare no conflicts of interest.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Subjective evaluation of barriers during SARS-CoV2 pandemic

References

    1. Immovilli P, Morelli N, Antonucci E, Radaelli G, Barbera M, Guidetti D. COVID-19 mortality and ICU admission: the Italian experience. Crit Care. 2020;24(1):228. doi: 10.1186/s13054-020-02957-9.
    1. Carenzo L, Costantini E, Greco M, Barra FL, Rendiniello V, Mainetti M. Hospital surge capacity in a tertiary emergency referral Centre during the COVID-19 outbreak in Italy. Anaesthesia. 2020;75(7):928–934. doi: 10.1111/anae.15072.
    1. Korobelnik J-F, Loewenstein A, Eldem B, Joussen AM, Koh A, Lambrou GN. Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. Graefes Arch Clin Exp Ophthalmol. 2020;258(6):1149–1156. doi: 10.1007/s00417-020-04703-x.
    1. Siedlecki J, Brantl V, Schworm B, Mayer WJ, Gerhardt M, Michalakis S. COVID-19: ophthalmological aspects of the SARS-CoV 2 global pandemic. Klin Monatsblätter Für Augenheilkd. 2020;237(05):675–680. doi: 10.1055/a-1164-9381.
    1. Hattenbach L, Heinz P, Feltgen N, Hoerauf H, Kohnen T, Priglinger S. Auswirkungen der SARS-CoV-2-Pandemie auf die ophthalmologische Versorgung in Deutschland. Ophthalmology. 2020;117(9):892–904. doi: 10.1007/s00347-020-01220-4.
    1. R Core Team . R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2016.
    1. Kanda Y. Investigation of the freely available easy-to-use software, EZR for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458. doi: 10.1038/bmt.2012.244.
    1. Posarelli C, Maglionico MN, Covello G, Loiudice P, Cipriano A, Santini M. Ophthalmological emergencies and the SARS-CoV-2 outbreak. PLOS ONE. 2020;15(10):e0239796. doi: 10.1371/journal.pone.0239796.
    1. Pellegrini M, Roda M, Lupardi E, Di Geronimo N, Giannaccare G, Schiavi C. The impact of COVID-19 pandemic on ophthalmological emergency department visits. Acta Ophthalmol 2020 [zitiert 9. Dezember 2020]; Verfügbar unter: 10.1111/aos.14489
    1. Guo H, Zhou Y, Liu X, Tan J. The impact of the COVID-19 epidemic on the utilization of emergency dental services. J Dent Sci. 2020; [zitiert 9. Dezember 2020]; Verfügbar unter: .
    1. Lucero A, Lee A, Hyun J, Lee C, Kahwaji C, Miller G. Underutilization of the emergency department during the COVID-19 pandemic. West J Emerg Med. 2020;21(6) [zitiert 9. Dezember 2020]. Verfügbar unter: .
    1. Al-khersan H, Kalavar MA, Tanenbaum R, Lazzarini TA, Patel NA, Yannuzzi NA. Emergent ophthalmic surgical care at a tertiary referral center during the COVID-19 pandemic. Am J Ophthalmol. 2021;222:368–372. doi: 10.1016/j.ajo.2020.08.044.
    1. Jasani KM, Ivanova T, Sabatino F, Patton N, Dhawahir-Scala F, Chew G. Changing clinical patterns of Rhegmatogeneous Retinal Detachments during the COVID19 pandemic lockdown in the North West of the UK. Eur J Ophthalmol. 2020;17:1120672120965480.
    1. Dick L, Green J, Brown J, Kennedy E, Cassidy R, Othman S. Changes in emergency general surgery during Covid-19 in Scotland: a prospective cohort study. World J Surg. 2020;44(11):3590–3594. doi: 10.1007/s00268-020-05760-3.
    1. Patriti A, Baiocchi GL, Catena F, Marini P, Catarci M, FACS on behalf of the Associazione Chirurghi Ospedalieri Italiani (ACOI) Emergency general surgery in Italy during the COVID-19 outbreak: first survey from the real life. World J Emerg Surg. 2020;15(1):36. doi: 10.1186/s13017-020-00314-3.
    1. Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020;4(5):e10–e11. doi: 10.1016/S2352-4642(20)30108-5.
    1. Fitzpatrick KM, Harris C, Drawve G. Fear of COVID-19 and the mental health consequences in America. Psychol Trauma Theory Res Pract Policy. 2020;12(S1):S17–S21. doi: 10.1037/tra0000924.
    1. Chan EYY, Huang Z, Lo ESK, Hung KKC, Wong ELY, Wong SYS. Sociodemographic predictors of health risk perception, attitude and behavior practices associated with health-emergency disaster risk management for biological hazards: The case of COVID-19 pandemic in Hong Kong, SAR China. Int J Environ Res Public Health. 2020;17(11):3869. doi: 10.3390/ijerph17113869.
    1. Bruine de Bruin W. Age differences in COVID-19 risk perceptions and mental health:Evidence from a national US survey conducted in March 2020. J Gerontol B Psychol Sci Soc Sci. 2020;76:e24–e29. doi: 10.1093/geronb/gbaa074.
    1. Du H, Zhang M, Zhang H, Sun X. Practical experience on emergency ophthalmic surgery during the prevalence of COVID-19. Graefes Arch Clin Exp Ophthalmol. 2020;258(8):1831–1833. doi: 10.1007/s00417-020-04692-x.
    1. Lim LW, Yip LW, Tay HW, Ang XL, Lee LK, Chin CF. Sustainable practice of ophthalmology during COVID-19: challenges and solutions. Graefes Arch Clin Exp Ophthalmol. 2020;258(7):1427–1436. doi: 10.1007/s00417-020-04682-z.
    1. Novick G. Is there a bias against telephone interviews in qualitative research? Res Nurs Health. 2008;31(4):391–398. doi: 10.1002/nur.20259.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe